BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:40 PM
Oct 30, 2007
 |  BC Extra  |  Company News

Europe approves Nexavar for HCC

The European Commission approved Nexavar sorafenib from Bayer (FSE:BAY; BAY) and Onyx (ONXX)...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >